We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
- Authors
Nawata, Masao; Nagayasu, Atsushi; Fujita, Yuya; Nawata, Aya; Saito, Kazuyoshi; Tanaka, Yoshiya
- Abstract
Background: Pulmonary arterial hypertension (PAH) and interstitial pneumonia (IP) are relatively rare complications of systemic lupus erythematosus (SLE) and are associated with a poor prognosis. Overcoming these complications is a challenge for improving the prognosis. Case report: A 41-year-old woman was diagnosed with SLE complicated by IP at the age of 21 years and with antiphospholipid syndrome at the age of 32 years at another hospital. She had been administered prednisolone (PSL) at a dose ≥15 mg daily, as well as various immunosuppressants and antiplatelet/anticoagulation therapy. On day I of hospitalization, She presented to our emergency outpatient department with fever, marked dyspnea, and skin ulcer on the left lower leg and was admitted the same day. Chest radiography revealed marked cardiomegaly and interstitial shadow, and right heart catheterization showed elevation in the mean pulmonary arterial pressure to 47 mmHg, indicating PAH. While oxygen therapy was started, high-dose steroid therapy and mycophenolate mofetil (MMF) were administered for treatment of SLE complicated by PAH/IP, and prostacyclin (prostaglandin I2), endothelin receptor antagonist, and PDE5 inhibitor were administered for PAH. Both SLE disease activity and PAH/IP improved and were maintained with no exacerbation for 2 years. The PSL dose could eventually be reduced to 5 mg/day. Conclusion: In SLE complicated by PAH/IP, reports on the efficacy of MMF are scarce, and our findings suggested that MMF may be a treatment option in such cases.
- Subjects
PULMONARY fibrosis; PULMONARY hypertension; MYCOPHENOLIC acid; SYSTEMIC lupus erythematosus; ANTIPHOSPHOLIPID syndrome; IDIOPATHIC interstitial pneumonias; ENDOTHELIN receptors
- Publication
Lupus, 2020, Vol 29, Issue 14, p1955
- ISSN
0961-2033
- Publication type
Article
- DOI
10.1177/0961203320958055